162 related articles for article (PubMed ID: 12677027)
1. Clinical research. A setback and an advance on the AIDS vaccine front.
Cohen J
Science; 2003 Apr; 300(5616):28-9. PubMed ID: 12677027
[No Abstract] [Full Text] [Related]
2. Policy rebuttal. HIV vaccine trial justified.
McNeil JG; Johnston MI; Birx DL; Tramont EC
Science; 2004 Feb; 303(5660):961. PubMed ID: 14963313
[No Abstract] [Full Text] [Related]
3. Thailand's Prime-Boost HIV Vaccine Phase III.
Trinvuthipong C
Science; 2004 Feb; 303(5660):954-5. PubMed ID: 14963308
[No Abstract] [Full Text] [Related]
4. Comparison of systemic and mucosal delivery of 2 canarypox virus vaccines expressing either HIV-1 genes or the gene for rabies virus G protein.
Wright PF; Mestecky J; McElrath MJ; Keefer MC; Gorse GJ; Goepfert PA; Moldoveanu Z; Schwartz D; Spearman PW; El Habib R; Spring MD; Zhu Y; Smith C; Flores J; Weinhold KJ;
J Infect Dis; 2004 Apr; 189(7):1221-31. PubMed ID: 15031791
[TBL] [Abstract][Full Text] [Related]
5. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J; Ngai N; Stone GW; Yue FY; Ostrowski MA
Vaccine; 2009 Aug; 27(37):5077-84. PubMed ID: 19573639
[TBL] [Abstract][Full Text] [Related]
6. RV144: old vs. new.
Weiner DB
Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
[No Abstract] [Full Text] [Related]
7. Prime-boost immunization strategies against HIV.
Barnett SW; Klinger JM; Doe B; Walker CM; Hansen L; Duliège AM; Sinangil FM
AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S299-309. PubMed ID: 9814958
[No Abstract] [Full Text] [Related]
8. [Prospects for vaccine development against HIV infection].
Kurth R; Binninger D; Ennen J; Denner J; Hartung S; Norley S
Verh Dtsch Ges Inn Med; 1991; 97():394-402. PubMed ID: 1808921
[No Abstract] [Full Text] [Related]
9. HIV adenovirus vaccine in Phase I trials.
Expert Rev Vaccines; 2003 Aug; 2(4):471. PubMed ID: 14711332
[No Abstract] [Full Text] [Related]
10. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
[TBL] [Abstract][Full Text] [Related]
11. Phase 1 clinical trials of the National Institutes of Health Vaccine Research Center HIV/AIDS candidate vaccines.
Robinson HL; Weinhold KJ
J Infect Dis; 2006 Dec; 194(12):1625-7. PubMed ID: 17109331
[No Abstract] [Full Text] [Related]
12. HIV vaccine may raise risk.
Ledford H
Nature; 2007 Nov; 450(7168):325. PubMed ID: 18004331
[No Abstract] [Full Text] [Related]
13. [Development of a vaccine against HIV: is this aim accomplishable?].
Wagner R; Asbach B
MMW Fortschr Med; 2013 Jun; 155 Suppl 1():36-9. PubMed ID: 23961653
[No Abstract] [Full Text] [Related]
14. Support for the RV144 HIV vaccine trial.
Belshe R; Franchini G; Girard MP; Gotch F; Kaleebu P; Marthas ML; McChesney MB; McCullough R; Mhalu F; Salmon-Ceron D; Sekaly RP; van Rompay K; Verrier B; Wahren B; Weissenbacher M
Science; 2004 Jul; 305(5681):177-80; author reply 177-80. PubMed ID: 15247455
[No Abstract] [Full Text] [Related]
15. Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women.
Johnson DC; McFarland EJ; Muresan P; Fenton T; McNamara J; Read JS; Hawkins E; Bouquin PL; Estep SG; Tomaras GD; Vincent CA; Rathore M; Melvin AJ; Gurunathan S; Lambert J
J Infect Dis; 2005 Dec; 192(12):2129-33. PubMed ID: 16288378
[TBL] [Abstract][Full Text] [Related]
16. Outstanding questions on HIV vaccine trial.
Jefferys R; Harrington M
Science; 2004 Jul; 305(5681):180; author reply 180. PubMed ID: 15247456
[No Abstract] [Full Text] [Related]
17. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
[No Abstract] [Full Text] [Related]
18. HIV/AIDS research. Surprising AIDS vaccine success praised and pondered.
Cohen J
Science; 2009 Oct; 326(5949):26-7. PubMed ID: 19797628
[No Abstract] [Full Text] [Related]
19. Vaccines for control of HIV infections.
Sharma KB
J Indian Med Assoc; 1994 Jan; 92(1):27-8. PubMed ID: 8207277
[No Abstract] [Full Text] [Related]
20. HIV/AIDS. Hedged bet: an unusual AIDS vaccine trial.
Cohen J
Science; 2005 Aug; 309(5737):1003. PubMed ID: 16099960
[No Abstract] [Full Text] [Related]
[Next] [New Search]